| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.13 | 0.008 |